Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoStart with Pro — $79/mo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

Back to SEC Filings
Executive ChangeItem 5.02 · 8-KMEDIUM RiskNeutral

GoodRx Holdings, Inc.

Filed: Mar 24, 2026Santa Monica, CaliforniaCIK: 0001809519
Watch CompanyView on SEC.gov

AI Executive Summary

AI-powered analysis of 8-K filing content

Chief Accounting Officer Romin Nabiey resigned from GoodRx Holdings effective April 3, 2026, to pursue other opportunities, with a transition period extending through June 8, 2026. This departure may impact financial reporting and oversight functions during the transition period.

Key Takeaways

Romin Nabiey's resignation as Chief Accounting Officer is voluntary and unrelated to any disagreements with company policies or operations

The resignation is effective April 3, 2026, but Mr. Nabiey will remain through June 8, 2026, to facilitate a structured transition

2 more takeaways

Related Filings (3)

3 more filings from GoodRx Holdings, Inc. in the last 90 days

Filing Overview

Form Type8-K
Filing DateMar 24, 2026
Item5.02
CategoryExecutive Change
CIK0001809519
Accession #gdrx-20260324
Risk LevelMEDIUM
SentimentNeutral
Signalinformational
Topics
executive departureleadership transition

What This Means

A senior executive (CEO, CFO, etc.) has joined, departed, or changed roles. Leadership changes can significantly impact strategy.
View Full Filing on SEC.govBrowse More Filings